|
pain |
7 |
|
analgesia |
6 |
|
spinal cord stimulation |
6 |
|
chronic pain |
5 |
|
diabetes mellitus |
5 |
|
endothelin-1 |
5 |
|
infarct size |
5 |
|
ischemia reperfusion injury |
5 |
|
neuropathic pain |
5 |
|
postoperative pain |
5 |
|
acute |
4 |
|
acute postoperative pain |
4 |
|
adult population |
4 |
|
aging |
4 |
|
alzheimer's disease |
4 |
|
amyloidosis |
4 |
|
astrocytes |
4 |
|
colorectal surgery |
4 |
|
dental |
4 |
|
dental surgery |
4 |
|
dexmedetomidine |
4 |
|
dexmedetomidine - administration and dosage |
4 |
|
distal radial fracture fixation |
4 |
|
general anesthesia |
4 |
|
heart failure |
4 |
|
infraclavicular nerve block |
4 |
|
ischemic stroke |
4 |
|
local |
4 |
|
opioid |
4 |
|
pain, postoperative - diagnosis - prevention and control |
4 |
|
postoperative analgesia |
4 |
|
postoperative opioid consumption |
4 |
|
prevalence |
4 |
|
propofol |
4 |
|
regional anesthesia |
4 |
|
sevoflurane |
4 |
|
tooth extraction - adverse effects |
4 |
|
total intravenous anesthesia |
4 |
|
allopurinol |
3 |
|
amp-activated protein kinase |
3 |
|
autophagy |
3 |
|
biological effects |
3 |
|
cancer |
3 |
|
colorectal |
3 |
|
diabetic cardiomyopathy |
3 |
|
endothelin type a receptor |
3 |
|
guidelines |
3 |
|
inflammation |
3 |
|
inflammatory pain |
3 |
|
mitochondria |
3 |
|
myocardial injury |
3 |
|
myocardial ischemia-reperfusion |
3 |
|
neuropathic |
3 |
|
non-cancer pain |
3 |
|
nrf2 |
3 |
|
nuclear factor of activated t-cells 5 |
3 |
|
nuclear factor-kappa b |
3 |
|
opioid requirements |
3 |
|
opioid rotation |
3 |
|
opioid therapy |
3 |
|
oxidative stress |
3 |
|
pain management |
3 |
|
painpaired box gene 2 |
3 |
|
parecoxib |
3 |
|
pharmacogenetics |
3 |
|
polymorphisms |
3 |
|
postoperative |
3 |
|
surgical injury |
3 |
|
adult |
2 |
|
adverse effects |
2 |
|
aged |
2 |
|
allodynia |
2 |
|
analgesics, opioid - administration & dosage - adverse effects |
2 |
|
anesthesia recovery period |
2 |
|
anesthesia, dental - methods |
2 |
|
anesthesia, dental/methods |
2 |
|
anesthesia, local |
2 |
|
blood component transfusion - standards |
2 |
|
coagulopathy |
2 |
|
conscious sedation - methods |
2 |
|
conscious sedation/methods |
2 |
|
coronavirus |
2 |
|
covid-19 |
2 |
|
deleted in liver cancer 2 (dlc2) |
2 |
|
dose-response relationship, drug |
2 |
|
drug administration schedule |
2 |
|
drug resistance - physiology |
2 |
|
electroencephalography - drug effects |
2 |
|
endothelial cells |
2 |
|
enhanced recovery after surgery |
2 |
|
environmental enrichment |
2 |
|
erythrocyte transfusion |
2 |
|
female |
2 |
|
fresh-frozen plasma |
2 |
|
hemorrhage - etiology - physiopathology - therapy |
2 |
|
humans |
2 |
|
hyperalgesia |
2 |
|
hypnotics and sedatives - administration & dosage - pharmacology |
2 |
|
il-1β |
2 |
|
infusions, intravenous - adverse effects - statistics & numerical data |
2 |
|
labor analgesia |
2 |
|
male |
2 |
|
medical audit |
2 |
|
mental recall - drug effects |
2 |
|
meperidine |
2 |
|
microgliap38 |
2 |
|
midazolam - administration & dosage - pharmacology |
2 |
|
middle aged |
2 |
|
molar, third - surgery |
2 |
|
monitoring, intraoperative - methods |
2 |
|
morphine |
2 |
|
morphine - administration & dosage - adverse effects |
2 |
|
oral oxycodone |
2 |
|
outcome assessment (health care) - methods |
2 |
|
pain measurement - methods |
2 |
|
pain, postoperative - drug therapy - physiopathology - prevention & control |
2 |
|
patient care team |
2 |
|
patient satisfaction |
2 |
|
patient-controlled |
2 |
|
pethidine |
2 |
|
plasma |
2 |
|
pneumonia |
2 |
|
post-operative |
2 |
|
postoperative care |
2 |
|
postoperative nausea and vomiting - chemically induced - epidemiology - prevention & control |
2 |
|
red blood cells |
2 |
|
respiratory insufficiency - chemically induced - epidemiology - prevention & control |
2 |
|
resuscitation - methods |
2 |
|
retrospective studies |
2 |
|
review |
2 |
|
rhoa rock |
2 |
|
sars-cov-2 |
2 |
|
self administration - adverse effects - statistics & numerical data |
2 |
|
time factors |
2 |
|
tooth extraction |
2 |
|
transfusion |
2 |
|
trauma |
2 |
|
treatment outcome |
2 |
|
young adult |
2 |
|
acute disease |
1 |
|
acute pain |
1 |
|
adrenergic alpha-2 receptor agonists - pharmacology - therapeutic use |
1 |
|
alpha-2 agonist |
1 |
|
analgesic and antitumor |
1 |
|
analgesics - pharmacology - therapeutic use |
1 |
|
analgesics, opioid - adverse effects - therapeutic use |
1 |
|
ap-1 |
1 |
|
asia |
1 |
|
blood component transfusion - methods |
1 |
|
c-jun |
1 |
|
carotid artery puncture |
1 |
|
central venous line cannulation |
1 |
|
chronic |
1 |
|
chronic disease |
1 |
|
clonidine |
1 |
|
cognition |
1 |
|
erythrocyte transfusion - methods |
1 |
|
extracellular signal-regulated map kinases - genetics - metabolism |
1 |
|
fadolmidine |
1 |
|
fused furo[2,3-d]pyrimidinone derivatives |
1 |
|
gdnf |
1 |
|
gene expression regulation, enzymologic - drug effects |
1 |
|
glial cell line-derived neurotrophic factor - metabolism - pharmacology |
1 |
|
hemorrhage - etiology - therapy |
1 |
|
internal jugular vein |
1 |
|
matrix metalloproteinase 13 - genetics - metabolism |
1 |
|
migration |
1 |
|
mmp-13 |
1 |
|
neuroglia - drug effects - physiology |
1 |
|
pain - drug therapy |
1 |
|
pain - drug therapy - physiopathology - psychology |
1 |
|
physicians |
1 |
|
pneumothorax |
1 |
|
quality of life |
1 |
|
questionnaire |
1 |
|
synthesis |
1 |
|
ultrasound |
1 |
|
wounds and injuries - complications - therapy |
1 |
